Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA. Coulombe F, et al. Among authors: de leseleuc l. J Exp Med. 2009 Aug 3;206(8):1709-16. doi: 10.1084/jem.20081779. Epub 2009 Jul 6. J Exp Med. 2009. PMID: 19581406 Free PMC article.
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.
Guan Q, Aktar SJ, Pataky RE, Stephen MM, Marques M, Gambaro K, Rachedi K, Forster K, Strub S, Stock D, de Léséleuc L, Cheung WY, Peacock S, Farrer C, Gavura S, Tadrous M, Grant RC, Chan KKW. Guan Q, et al. Among authors: de leseleuc l. Curr Oncol. 2024 Jun 19;31(6):3591-3602. doi: 10.3390/curroncol31060264. Curr Oncol. 2024. PMID: 38920747 Free PMC article.
Esketamine for Treatment-Resistant Depression.
Tibensky BN, de Léséleuc L, Perras C, Picheca L. Tibensky BN, et al. Among authors: de leseleuc l. 2019 Apr 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 176. 2019 Apr 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 176. PMID: 31211546 Free Books & Documents. Review.
Voretigene Neparvovec: An Emerging Gene Therapy for the Treatment of Inherited Blindness.
Patel U, Boucher M, de Léséleuc L, Visintini S. Patel U, et al. Among authors: de leseleuc l. 2018 Mar 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 169. 2018 Mar 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 169. PMID: 30855774 Free Books & Documents. Review.
12 results